Celiac Disease: A Storm of Gluten Intolerance
Celiac disease (CD) is an autoimmune disorder mediated by the ingestion of gluten in genetically susceptible individuals. Once thought rare, CD is now known to be significantly underdiagnosed, with prevalence having increased fourfold since 1950. In adults, especially older adults, presentation is often atypical, challenging clinicians to consider CD in patients with other autoimmune disorders, a family history of CD, or certain nongastrointestinal manifestations, including anemia, fatigue, osteoporosis, and infertility.
28. Logan RFA. Problems and pitfalls in epidemiological studies of coeliac disease. In: Auricchio S, Visakorpi JK, eds. Common Food Intolerances 1. Epidemiology of Coeliac Disease (Dynamic Nutrition Research)(Pt 1). Basel, Switzerland: Karger; 1992:14-22.
29. Marsh MN. Gluten, major histocompatibility complex, and the small intestine: a molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’). Gastroenterology. 1992;102(1):330-354.
30. Oberhuber G, Granditsch G, Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol. 1999;11(10):1185-1194.
31. Corazza GR, Villanaci V. Coeliac disease.
J Clin Pathol. 2005;58(6):573-574.
32. Hadithi M, von Blomberg BM, Crusius JB, et al. Accuracy of serologic tests and HLA-DQ typing for diagnosing celiac disease. Ann Intern Med. 2007;147(5):294-302.
33. Lerner A. New therapeutic strategies for celiac disease. Autoimmun Rev. 2010;9(3):144-147.
34. Catassi C, Fasano A. Celiac disease diagnosis: simple rules are better than complicated algorithms. Am J Med. 2010;123(8):691-693.
35. Rubio-Tapia A, Kyle RA, Kaplan EL, et al. Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology. 2009; 137(1):88–93.
36. Harewood GC, Holub JL, Lieberman DA. Variation in small bowel biopsy performance among diverse endoscopy settings: results from a national endoscopic database. Am J Gastroenterol. 2004;99(9):1790-1794.
37. Brar P, Lee S, Lewis S, et al. Budesonide in the treatment of refractory celiac disease. Am J Gastroenterol. 2007;102(10):2265-2269.
38. Al-Toma A, Verbeek WHM, Hadithi M, et al. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut. 2007;56(10):1373-1378.
39. Kaukinen K, Mäki M, Partanen J, et al. Celiac disease without villous atrophy: revision of criteria called for. Dig Dis Sci. 2001;46(4):879-887.
40. Mohamed BM, Feighery C, Coates C, et al. The absence of a mucosal lesion on standard histological examination does not exclude diagnosis of celiac disease. Dig Dis Sci. 2008; 53(1):52-61.
41. Fasano A, Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology. 2001; 120(3):636-651.
42. US Food and Drug Administration. Topic-specific labeling information (2010). www.fda.gov/Food/LabelingNutrition/FoodLabeling GuidanceRegulatoryInformation/Topic-Specific LabelingInformation/default.htm. Accessed March 28, 2011.
43. Lindfors K, Blomqvist T, Juuti-Uusitalo K, et al. Live probiotic Bifidobacterium lactis bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture. Clin Exp Immunol. 2008;152(3):552-558.
44. Cellier C, Delabesse E, Helmer C, et al; French Coeliac Disease Study Group. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. Lancet. 2000;356(9225): 203-208.
45. United European Gastroenterology. When is a coeliac a coeliac? Report of a working group of the United European Gastroenterology Week in Amsterdam, 2001. Eur J Gastroenterol Hepatol. 2001;13(9):1123-1128.
46. Malamut G, Afchain P, Verkarre V, et al. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology. 2009;136(1):81-90.
47. Al-Toma A, Goerres MS, Meijer JW, et al. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma. Clin Gastroenterol Hepatol. 2006;4(3): 315-319.
48. Mauriño E, Niveloni S, Cherñavsky A, et al. Azathioprine in refractory sprue: results from a prospective, open-label study. Am J Gastroenterol. 2002;97(10):2595–2602.
49. Tack GJ, Verbeek WHM, Al-Toma A, et al. Evaluation of cladribine treatment in refractory celiac disease type II. World J Gastroenterol. 2011;17(4):506–513.
50. Akobeng AK, Ramanan AV, Buchan I, Heller RF. Effect of breast feeding on risk of coeliac disease: a systematic review and meta-analysis of observational studies. Arch Dis Child. 2006; 91(1):39-43.
51. Rashid M, Butzner JD, Warren R, et al. Home blood testing for celiac disease: recommendations for management. Can Fam Physician. 2009;55(2):151-153.
52. Hershcovici T, Leshno M, Goldin E, et al. Cost effectiveness of mass screening for coeliac disease is determined by time-delay to diagnosis and quality of life on a gluten-free diet. Aliment Pharmacol Ther. 2010;31(8):901-910.
